GoodRx Holdings Cash on Hand 2019-2026 | GDRX
GoodRx Holdings cash on hand from 2019 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
GoodRx Holdings Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $262 |
| 2024 | $448 |
| 2023 | $672 |
| 2022 | $757 |
| 2021 | $941 |
| 2020 | $972 |
| 2019 | $26 |
| 2018 | $35 |
|
GoodRx Holdings Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2026-06-30 | $296 |
| 2026-03-31 | $236 |
| 2025-12-31 | $262 |
| 2025-09-30 | $274 |
| 2025-06-30 | $281 |
| 2025-03-31 | $301 |
| 2024-12-31 | $448 |
| 2024-09-30 | $424 |
| 2024-06-30 | $525 |
| 2024-03-31 | $533 |
| 2023-12-31 | $672 |
| 2023-09-30 | $795 |
| 2023-06-30 | $762 |
| 2023-03-31 | $761 |
| 2022-12-31 | $757 |
| 2022-09-30 | $729 |
| 2022-06-30 | $731 |
| 2022-03-31 | $845 |
| 2021-12-31 | $941 |
| 2021-09-30 | $912 |
| 2021-06-30 | $895 |
| 2021-03-31 | $993 |
| 2020-12-31 | $972 |
| 2020-09-30 | $1,078 |
| 2018-12-31 | $35 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.158B | $0.797B |
| GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.899B | 26.08 |
| CVS Health (CVS) | United States | $113.624B | 11.33 |
| HCA Healthcare (HCA) | United States | $92.600B | 14.40 |
| Elevance Health (ELV) | United States | $89.122B | 13.98 |
| Cencora (COR) | United States | $58.924B | 18.00 |
| Natera (NTRA) | United States | $53.245B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.010B | 18.34 |
| Viatris (VTRS) | United States | $19.469B | 6.73 |
| Medpace Holdings (MEDP) | United States | $17.091B | 35.89 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.888B | 0.00 |
| DiDi Global (DIDIY) | China | $16.776B | 184.00 |
| Revvity (RVTY) | United States | $16.007B | 26.81 |
| Solventum (SOLV) | United States | $15.123B | 12.51 |
| Charles River Laboratories (CRL) | United States | $13.274B | 28.09 |
| ICON (ICLR) | Ireland | $12.565B | 17.08 |
| BrightSpring Health Services (BTSG) | United States | $11.235B | 38.63 |
| Avantor (AVTR) | United States | $10.497B | 18.93 |
| BioMerieux (BMXMF) | France | $9.856B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.472B | 83.28 |
| HealthEquity (HQY) | United States | $7.870B | 25.64 |
| Sonic Healthcare (SKHHY) | Australia | $6.732B | 0.00 |
| PACS (PACS) | United States | $6.666B | 22.40 |
| GETINGE (GNGBY) | Sweden | $6.516B | 18.40 |
| CochLear (CHEOY) | Australia | $6.200B | 0.00 |
| MiniMed (MMED) | United States | $6.131B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.021B | 22.77 |
| Sotera Health (SHC) | United States | $5.345B | 22.03 |
| Concentras Parent (CON) | United States | $4.523B | 22.31 |
| Organon (OGN) | United States | $3.593B | 4.56 |
| GeneDx Holdings (WGS) | United States | $3.015B | 280.83 |
| CareDx (CDNA) | United States | $2.785B | 316.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.107B | 12.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.103B | 0.00 |
| Progyny (PGNY) | United States | $2.082B | 29.49 |
| Establishment Labs Holdings (ESTA) | United States | $2.065B | 0.00 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $2.011B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.839B | 0.00 |
| Freenome (FRNM) | United States | $1.838B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.735B | 66.25 |
| Alignment Healthcare (ALHC) | United States | $1.732B | 43.95 |
| Agilon Health (AGL) | United States | $1.497B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Ardent Health (ARDT) | United States | $1.478B | 8.45 |
| Nutex Health (NUTX) | United States | $1.430B | 8.20 |
| Omada Health (OMDA) | United States | $1.251B | 255.38 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.145B | 0.00 |
| CryoPort (CYRX) | United States | $0.862B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.677B | 0.00 |
| Forward Industries (FWDI) | United States | $0.569B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.489B | 10.11 |
| Strata Critical Medical (SRTA) | United States | $0.472B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.378B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.48 |
| Biodesix (BDSX) | United States | $0.308B | 0.00 |
| Embecta (EMBC) | United States | $0.300B | 2.59 |
| So-Young (SY) | China | $0.279B | 0.00 |
| LifeMD (LFMD) | United States | $0.155B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.101B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.097B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.082B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.073B | 8.67 |
| Tevogen (TVGN) | United States | $0.051B | 0.00 |
| DocGo (DCGO) | United States | $0.036B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |